JOURNAL BROWSE
Search
Advanced SearchSearch Tips
The serine threonine kinase RIP3: lost and found
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : BMB Reports
  • Volume 48, Issue 6,  2015, pp.303-312
  • Publisher : Korean Society for Biochemistry and Molecular Biology
  • DOI : 10.5483/BMBRep.2015.48.6.068
 Title & Authors
The serine threonine kinase RIP3: lost and found
Morgan, Michael J.; Kim, You-Sun;
  PDF(new window)
 Abstract
Receptor-interacting protein kinase-3 (RIP3, or RIPK3) is an essential protein in the "programmed", or "regulated" necrosis cell death pathway that is activated in response to death receptor ligands and other types of cellular stress. Programmed necrotic cell death is distinguished from its apoptotic counterpart in that it is not characterized by the activation of caspases; unlike apoptosis, programmed necrosis results in plasma membrane rupture, thus spilling the contents of the cell and triggering the activation of the immune system and inflammation. Here we discuss findings, including our own recent data, which show that RIP3 protein expression is absent in many cancer cell lines. The recent data suggests that the lack of RIP3 expression in a majority of these deficient cell lines is due to methylation-dependent silencing, which limits the responses of these cells to pro-necrotic stimuli. Importantly, RIP3 expression may be restored in many cancer cells through the use of hypomethylating agents, such as decitabine. The potential implications of loss of RIP3 expression in cancer are explored, along with possible consequences for chemotherapeutic response. [BMB Reports 2015; 48(6): 303-312]
 Keywords
Hypomethylating agents;Programmed Necrosis;RIP3 (RIPK3);
 Language
English
 Cited by
1.
A Bak-dependent mitochondrial amplification step contributes to Smac mimetic/glucocorticoid-induced necroptosis, Cell Death and Differentiation, 2016  crossref(new windwow)
 References
1.
Vandenabeele P, Galluzzi L, Vanden Berghe T and Kroemer G (2010) Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 11, 700-714 crossref(new window)

2.
Vanlangenakker N, Vanden Berghe T and Vandenabeele P (2012) Many stimuli pull the necrotic trigger, an overview. Cell Death Differ 19, 75-86 crossref(new window)

3.
Morgan M and Liu Z (2013) Programmed cell death with a necrotic-like phenotype. Biomol Concepts 4, 259-275 crossref(new window)

4.
Kroemer G, El-Deiry WS, Golstein P et al (2005) Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ 12 Suppl 2, 1463-1467 crossref(new window)

5.
Fiers W, Beyaert R, Declercq W and Vandenabeele P (1999) More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncogene 18, 7719-7730 crossref(new window)

6.
Moriwaki K and Chan FKM (2013) RIP3: a molecular switch for necrosis and inflammation. Genes Dev 27, 1640-1649 crossref(new window)

7.
Linkermann A, Brasen JH, Darding M et al (2013) Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury. Proc Nat Acad Sci U S A 110, 12024-12029 crossref(new window)

8.
Kaiser WJ, Upton JW and Mocarski ES (2013) Viral modulation of programmed necrosis. Curr Opin Virol 3, 296-306 crossref(new window)

9.
Ofengeim D, Ito Y, Najafov A et al (2015) Activation of Necroptosis in Multiple Sclerosis. Cell Rep 10, 1836-1849 crossref(new window)

10.
Lin Y, Choksi S, Shen HM et al (2004) Tumor necrosis factor-induced nonapoptotic cell death requires receptor- interacting protein-mediated cellular reactive oxygen species accumulation. J Biol Chem 279, 10822-10828 crossref(new window)

11.
Holler N, Zaru R, Micheau O et al (2000) Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 1, 489-495 crossref(new window)

12.
Morgan MJ and Liu ZG (2010) Reactive oxygen species in TNFalpha-induced signaling and cell death. Mol Cells 30, 1-12 crossref(new window)

13.
Devin A, Lin Y and Liu ZG (2003) The role of the deathdomain kinase RIP in tumour-necrosis-factor-induced activation of mitogen-activated protein kinases. EMBO Rep 4, 623-627 crossref(new window)

14.
Degterev A, Hitomi J, Germscheid M et al (2008) Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 4, 313-321 crossref(new window)

15.
Chan FK, Shisler J, Bixby JG et al (2003) A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses. J Biol Chem 278, 51613-51621 crossref(new window)

16.
Degterev A, Huang Z, Boyce M et al (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1, 112-119 crossref(new window)

17.
Cho YS, Challa S, Moquin D et al (2009) Phosphorylationdriven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137, 1112-1123 crossref(new window)

18.
He S, Wang L, Miao L et al (2009) Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 137, 1100-1111 crossref(new window)

19.
Zhang DW, Shao J, Lin J et al (2009) RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325, 332-336 crossref(new window)

20.
Sun X, Yin J, Starovasnik MA, Fairbrother WJ and Dixit VM (2002) Identification of a novel homotypic interaction motif required for the phosphorylation of receptor-interacting protein (RIP) by RIP3. J Biol Chem 277, 9505-9511 crossref(new window)

21.
Li J, McQuade T, Siemer AB et al (2012) The RIP1/RIP3 Necrosome Forms a Functional Amyloid Signaling Complex Required for Programmed Necrosis. Cell 150, 339-350 crossref(new window)

22.
Rickard JA, O'Donnell JA, Evans JM et al (2014) RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Cell 157, 1175-1188 crossref(new window)

23.
Dillon CP, Weinlich R, Rodriguez DA et al (2014) RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3. Cell 157, 1189-1202 crossref(new window)

24.
Orozco S, Yatim N, Werner MR et al (2014) RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis. Cell Death Differ 21, 1511-1521 crossref(new window)

25.
Dannappel M, Vlantis K, Kumari S et al (2014) RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature 513, 90-94 crossref(new window)

26.
Zhao J, Jitkaew S, Cai Z et al (2012) Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proc Natl Acad Sci U S A 109, 5322-5327 crossref(new window)

27.
Sun L, Wang H, Wang Z et al (2012) Mixed lineage kinase domain-like protein mediates necrosis signaling down-stream of RIP3 kinase. Cell 148, 213-227 crossref(new window)

28.
Wu JF, Huang Z, Ren JM et al (2013) Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis. Cell Res 23, 994-1006 crossref(new window)

29.
Murphy JM, Czabotar PE, Hildebrand JM et al (2013) The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 39, 443-453 crossref(new window)

30.
Wang HY, Sun LM, Su LJ et al (2014) Mixed Lineage Kinase Domain-like Protein MLKL Causes Necrotic Membrane Disruption upon Phosphorylation by RIP3. Mol Cell 54, 133-146 crossref(new window)

31.
Cai ZY, Jitkaew S, Zhao J et al (2014) Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat Cell Biol 16, 55-56 crossref(new window)

32.
Chen X, Li WJ, Ren JM et al (2014) Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death. Cell Res 24, 105-121 crossref(new window)

33.
Dondelinger Y, Declercq W, Montessuit S et al (2014) MLKL Compromises Plasma Membrane Integrity by Binding to Phosphatidylinositol Phosphates. Cell Rep 7, 971-981 crossref(new window)

34.
Hildebrand JM, Tanzer MC, Lucet IS et al (2014) Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death. Proc Natl Acad Sci U S A 111, 15072-15077 crossref(new window)

35.
Cook WD, Moujalled DM, Ralph TJ et al (2014) RIPK1-and RIPK3-induced cell death mode is determined by target availability. Cell Death Differ 21, 1600-1612 crossref(new window)

36.
Bonnet MC, Preukschat D, Welz PS et al (2011) The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation. Immunity 35, 572-582 crossref(new window)

37.
Ch'en IL, Tsau JS, Molkentin JD, Komatsu M and Hedrick SM (2011) Mechanisms of necroptosis in T cells. J Exp Med 208, 633-641 crossref(new window)

38.
Dillon CP, Oberst A, Weinlich R et al (2012) Survival function of the FADD-CASPASE-8-cFLIP(L) complex. Cell Rep 1, 401-407 crossref(new window)

39.
Kaiser WJ, Upton JW, Long AB et al (2011) RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471, 368-372 crossref(new window)

40.
Lu JV, Weist BM, van Raam BJ et al (2011) Complementary roles of Fas-associated death domain (FADD) and receptor interacting protein kinase-3 (RIPK3) in T-cell homeostasis and antiviral immunity. Proc Natl Acad Sci U S A 108, 15312-15317 crossref(new window)

41.
Moulin M, Anderton H, Voss AK et al (2012) IAPs limit activation of RIP kinases by TNF receptor 1 during development. EMBO J 31, 1679-1691 crossref(new window)

42.
Oberst A, Dillon CP, Weinlich R et al (2011) Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 471, 363-367 crossref(new window)

43.
Zhang HB, Zhou XH, McQuade T, Li JH, Chan FKM and Zhang JK (2011) Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature 471, 373-376 crossref(new window)

44.
Vercammen D, Beyaert R, Denecker G et al (1998) Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med 187, 1477-1485 crossref(new window)

45.
Lin Y, Devin A, Rodriguez Y and Liu ZG (1999) Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev 13, 2514-2526 crossref(new window)

46.
Feng S, Yang Y, Mei Y et al (2007) Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain. Cell Signal 19, 2056-2067 crossref(new window)

47.
O'Donnell MA, Perez-Jimenez E, Oberst A et al (2011) Caspase 8 inhibits programmed necrosis by processing CYLD. Nat Cell Biol 13, 1437-1442 crossref(new window)

48.
Lu JV, Weist BM, van Raam BJ et al (2011) Complementary roles of Fas-associated death domain (FADD) and receptor interacting protein kinase-3 (RIPK3) in T-cell homeostasis and antiviral immunity. Proc Nat Acad Sci U S A 108, 15312-15317 crossref(new window)

49.
Gunther C, Martini E, Wittkopf N et al (2011) Caspase-8 regulates TNF-alpha-induced epithelial necroptosis and terminal ileitis. Nature 477, 335-U108 crossref(new window)

50.
Welz PS, Wullaert A, Vlantis K et al (2011) FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature 477, 330-U102 crossref(new window)

51.
Grooten J, Goossens V, Vanhaesebroeck B and Fiers W (1993) Cell membrane permeabilization and cellular collapse, followed by loss of dehydrogenase activity: early events in tumour necrosis factor-induced cytotoxicity. Cytokine 5, 546-555 crossref(new window)

52.
Laster SM, Wood JG and Gooding LR (1988) Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J Immunol 141, 2629-2634

53.
Denecker G, Vercammen D, Steemans M et al (2001) Death receptor-induced apoptotic and necrotic cell death: differential role of caspases and mitochondria. Cell Death Differ 8, 829-840 crossref(new window)

54.
Sakon S, Xue X, Takekawa M et al (2003) NF-kappaB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J 22, 3898-3909 crossref(new window)

55.
Yu PW, Huang BCB, Shen M et al (1999) Identification of RIP3, a RIP-like kinase that activates apoptosis and NF kappa B. Curr Biol 9, 539-542 crossref(new window)

56.
Sun XQ, Lee J, Navas T, Baldwin DT, Stewart TA and Dixit VM (1999) RIP3, a novel apoptosis-inducing kinase. J Biol Chem 274, 16871-16875 crossref(new window)

57.
Kasof GM, Prosser JC, Liu DR, Lorenzi MV and Gomes BC (2000) The RIP-like kinase, RIP3, induces apoptosis and NF-kappa B nuclear translocation and localizes to mitochondria. FEBS Lett 473, 285-291 crossref(new window)

58.
Koo G-B, Morgan MJ, Lee D-G et al (2015) MethylationDependent Loss of RIP3 Expression in Cancer Represses Programmed Necrosis in Response to Chemotherapeutics. Cell Res 25, 707-725 crossref(new window)

59.
Yang Y, Hu W, Feng S, Ma J and Wu M (2005) RIP3 beta and RIP3 gamma, two novel splice variants of receptor-interacting protein 3 (RIP3), downregulate RIP3-induced apoptosis. Biochem Biophys Res Commun 332, 181-187 crossref(new window)

60.
Newton K, Sun XQ and Dixit VM (2004) Kinase RIP3 is dispensable for normal NF-KBs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and toll-like receptors 2 and 4. Mol Cell Biol 24, 1464-1469 crossref(new window)

61.
Hanahan D and Weinberg RA (2011) Hallmarks of Cancer: The Next Generation. Cell 144, 646-674 crossref(new window)

62.
Nugues AL, El Bouazzati H, Hetuin D et al (2014) RIP3 is downregulated in human myeloid leukemia cells and modulates apoptosis and caspase-mediated p65/RelA cleavage. Cell Death Dis 5, e1384 crossref(new window)

63.
Liu XY, Lai F, Yan XG et al (2015) RIP1 Kinase Is an Oncogenic Driver in Melanoma. Cancer Res 75, 1736-1748 crossref(new window)

64.
Fukasawa M, Kimura M, Morita S et al (2006) Microarray analysis of promoter methylation in lung cancers. J Hum Genet 51, 368-374 crossref(new window)

65.
Zong WX, Ditsworth D, Bauer DE, Wang ZQ and Thompson CB (2004) Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev 18, 1272-1282 crossref(new window)

66.
David KK, Andrabi SA, Dawson TM and Dawson VL (2009) Parthanatos, a messenger of death. Front Biosci 14, 1116-1128 crossref(new window)

67.
Sosna J, Voigt S, Mathieu S et al (2014) TNF-induced necroptosis and PARP-1-mediated necrosis represent distinct routes to programmed necrotic cell death. Cell Mol Life Sci 71, 331-348 crossref(new window)

68.
Tenev T, Bianchi K, Darding M et al (2011) The Ripoptosome, a Signaling Platform that Assembles in Response to Genotoxic Stress and Loss of IAPs. Mol Cell 43, 432-448 crossref(new window)

69.
Feoktistova M, Geserick P, Kellert B et al (2011) cIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP Isoforms. Mol Cell 43, 449-463 crossref(new window)

70.
Biton S and Ashkenazi A (2011) NEMO and RIP1 control cell fate in response to extensive DNA damage via TNF-alpha feedforward signaling. Cell 145, 92-103 crossref(new window)

71.
Li JX, Feng JM, Wang Y et al (2014) The B-Raf(V600E) inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury. Cell Death Dis 5, e1278 crossref(new window)

72.
Kim SK, Kim WJ, Yoon JH et al (2015) Upregulated RIP3 Expression Potentiates MLKL Phosphorylation-Mediated Programmed Necrosis in Toxic Epidermal Necrolysis. J Invest Dermatol [Epub ahead of print]

73.
Motani K, Kushiyama H, Imamura R, Kinoshita T, Nishiuchi T and Suda T (2011) Caspase-1 Protein Induces Apoptosis-associated Speck-like Protein Containing a Caspase Recruitment Domain (ASC)mediated Necrosis Independently of Its Catalytic Activity. J Biol Chem 286, 33963-33972 crossref(new window)